Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

CTI BioPharma Corp. (CTIC)

1.69 -0.02 (-1.17%)

11-16 16:00

Open:

1.71

Pre. Close:

1.71

High:

1.74

Low:

1.69

Volume:

85,505

Market Cap:

98M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.744 - 1.753

1.753 - 1.76

Low:

1.666 - 1.678

1.678 - 1.687

Close:

1.674 - 1.691

1.691 - 1.705

Technical analysis  (as of: 2018-11-16 4:32:15 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 2.25     One year: 2.46

Support:

Support1: 1.64    Support2: 1.36

Resistance:

Resistance1: 1.93    Resistance2: 2.11

Pivot:

1.72

Moving Averages:

MA(5): 1.69     MA(20): 1.75

MA(100): 2.31     MA(250): 3.15

MACD:

MACD(12,26): -0.07     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 27.56     %D(3): 22.07

RSI:

RSI(14): 38.85

52-Week:

High: 5.36  Low: 1.64  Change(%): -40.1

Average Vol(K):

3-Month: 25921  10-Days 23125

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CTIC has closed above bottom band by 32.6%. Bollinger Bands are 82.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to CTIC's normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-11-16T08:48:16-05:00
European advisory group backs CTI Bio's pacritinib for certain myelofibrosis patients

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

57.99

Shares Float (M)

50.56

% Held by Insiders

% Held by Institutions

23.60

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

-1.260

EPS Est. Next Year

-1.870

EPS Est. Next Quarter

Forward EPS

-0.800

Book Value (p.s.)

1.820

PEG Ratio

Profit Margin

Operating Margin

-313.85

Return on Assets (ttm)

-57.6

Return on Equity (ttm)

-99.1

Qtrly Rev. Growth

-97.2

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-46.36

Levered Free Cash Flow (M)

-28.05

Valuation

P/E

P/E Growth Ratio

P/BV

0.93

P/S

362911872.00

P/CF

-2.11

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-01-03

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.